Search

Search Constraints

You searched for: Author/Creator Fan, Chunpeng

Search Results

3. Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Issue 1 (23rd October 2019)

4. Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds. (24th November 2021)

5. Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis. Issue 4 (21st January 2019)

6. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Issue 10209 (2nd November 2019)